Initiation Of Enrollment In Pivotal Phase III Clinical Study Of Oral Laquinimod For Relapsing-Remitting Multiple Sclerosis
Jerusalem, Israel and Lund, Sweden,
Teva Pharmaceutical Industries Ltd. ... more »
|
|||
|
Multiple Sclerosis Info
Search
This Month
|
Sunday, December 30
Initiation Of Enrollment In Pivotal Phase III Clinical Study Of Oral Laquinimod For RRMS
by
multiplesclerosis
on Sun 30 Dec 2007 09:18 AM CST
Can a vitamin alleviate chronic, progressive MS?
by
multiplesclerosis
on Sun 30 Dec 2007 09:13 AM CST
Can a vitamin alleviate chronic, progressive multiple sclerosis? Sunday, December 23
Using Pedometers to Increase Physical Activity and Improve Health
by
multiplesclerosis
on Sun 23 Dec 2007 12:00 AM CST
Using Pedometers to Increase Physical Activity and Improve Health
Context Without detailed evidence of their effectiveness,pedometers have recently become popular as a tool ... more » Friday, December 14
Treatment with Natalizumab in Patients with Multiple Sclerosis
by
multiplesclerosis
on Fri 14 Dec 2007 04:00 AM CST
Treatment with Natalizumab in Patients with Multiple Sclerosis Is Associated with Increased Numbers of Circulating CD34+ Cells in the Peripheral Blood.
Introduction:
Under physiological ... more » Monday, December 10
Optical coherence tomography and disease subtype in multiple sclerosis.
by
multiplesclerosis
on Mon 10 Dec 2007 12:00 AM CST
Optical coherence tomography and disease subtype in multiple sclerosis.
Department of Neurology, Johns Hopkins University, School of Medicine, Baltimore, MD, USA. To examine ... more »
Sunday, December 2
Rituximab in Adults With Relapsing-Remitting Multiple Sclerosis (RRMS)
by
multiplesclerosis
on Sun 02 Dec 2007 12:00 AM CST
Rituximab in Adults With Relapsing-Remitting Multiple Sclerosis: PRAGUE, CZECH REPUBLIC – A single course of rituximab is safe and well tolerated, and compared ... more » |
||